Danaher DHR
NYSE DHR
$234.59 -0.53 (-0.23%)
As of: Nov 10, 2026 · 1:08 PM EST

Danaher (DHR) Cash from Restructuring (2016 - 2018)

Updated

Danaher's Cash from Restructuring was $1.7 million in Q4 2018.

Analysis

Danaher (DHR) Cash from Restructuring (2016 - 2018) Analysis & Trends

  • Cash from Restructuring shows a three-year compound annual growth rate of -22.1% (FY2015 to FY2018).
  • In earlier years, Cash from Restructuring was $49.3 million in FY2017 (+310.8%), $12 million in FY2016 (+233.3%) and $3.6 million in FY2015.
  • The Q4 2018 figure marks the highest quarterly Cash from Restructuring since Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn
10 Agilent Technologies 50.16 Bn 43.05 Bn 1.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 1.70 Mn
Dec 31, 2016 12.00 Mn
API Access

Danaher Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=DHR&period=max&api_key=YOUR_API_KEY